Larvol Delta - Reevaluation-of-the-Bayesian-network-model-to-support-immunotherapy-decisionmaking-in-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Keytruda (pembrolizumab) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42789152

Andreas Dietz; Jan Gaebel; Johannes Stoehr; Matthaeus Stoehr

Sep 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next